Aziz Sawaf serves as Executive at Theravance Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Aziz Sawaf has executed 12 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 20, 2026 involved selling 20,672 shares valued at $406.4K.
Aziz Sawaf currently holds 316,123 shares of Theravance Biopharma, Inc. (TBPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Aziz Sawaf has been a net neutral trader of TBPH stock. They have purchased $0 and sold $0 worth of shares.
Aziz Sawaf's most recent insider trade was on Feb 20, 2026, when they sold 20,672 shares at $19.66 per share.
Get notified when new Form 4 filings are submitted
| $17.90 |
| Discretionary |
| Aug 20, 2025 | TBPH | $125.4K | Payment | 9,368 | $13.39 | Discretionary |
| Aug 20, 2024 | TBPH | $71.0K | Payment | 8,635 | $8.22 | Discretionary |
| May 20, 2024 | TBPH | $78.6K | Payment | 8,635 | $9.10 | Discretionary |
| Apr 2, 2024 | TBPH | $0 | Award | 100,000 | $N/A | Discretionary |
| Feb 20, 2024 | TBPH | $152.0K | Payment | 17,036 | $8.92 | Discretionary |
| Nov 20, 2023 | TBPH | $64.2K | Payment | 6,187 | $10.37 | Discretionary |
| Aug 20, 2023 | TBPH | $69.0K | Payment | 7,114 | $9.70 | Discretionary |
| May 20, 2023 | TBPH | $98.0K | Payment | 8,744 | $11.21 | Discretionary |
| Mar 1, 2023 | TBPH | $0 | Award | 80,000 | $N/A | Discretionary |
| Feb 20, 2023 | TBPH | $70.8K | Payment | 6,783 | $10.44 | Discretionary |